Christina Bourgeois, MB (ASCP)

Christina Bourgeois, MB (ASCP), has a diverse work experience in the field of research and diagnostics. Christina is currently employed at Stoke Therapeutics as an Associate Scientist, having taken on this role in January 2022. Prior to this, they worked at Stoke Therapeutics as a Senior Research Associate from May 2018 to December 2021.

Before joining Stoke Therapeutics, Christina worked at CRISPR Therapeutics as a Senior Research Associate from October 2017 to May 2018, and as a Research Associate from August 2015 to October 2017. During their time at CRISPR Therapeutics, they gained extensive experience in next-generation sequencing platforms and a variety of molecular techniques. Christina also contributed to the establishment of quality control processes and participated in biosafety and compliance activities.

From March 2014 to May 2015, Christina worked at Foundation Medicine as a Clinical Laboratory Technologist. Prior to that, they worked at Strata Pathology Services Inc. as a Molecular Technologist from June 2012 to February 2014.

Christina started their career as a Molecular Diagnostics Technician Intern at Yale DNA Diagnostics Laboratory in 2011. Christina gained skills in genetic testing, data analysis, karyotyping, and report writing during their internship.

Christina also has experience outside the scientific field, having worked as a Temporary Receptionist/Administrative Assistant at BONNEY Staffing Center in June 2008 to August 2008, where they handled phone systems and provided customer service.

Overall, Christina Bourgeois has a strong background in research, molecular diagnostics, and laboratory operations, with a focus on next-generation sequencing, molecular techniques, and compliance activities.

Christina Bourgeois, MB (ASCP), has a diverse education history focused on program management and molecular genetics. Christina obtained their Bachelor of Science (B.S.) degree with a concentration in Diagnostic Genetics from the University of Connecticut in 2011. Following this, they successfully completed a Master of Business Administration (MBA) program with a specialization in Program Management at Southern New Hampshire University, which they are expected to complete in 2022.

In addition to their formal education, Christina Bourgeois holds a certification as a Technologist in Molecular Biology from the American Society for Clinical Pathology (ASCP), which they earned in September 2013. This certification highlights their expertise in the field and further enhances their qualifications.